• Thu news: Industry M&A volume down 8% over 2023. Pfizer’s Ibrance improves breast cancer survival. Lonza shedding capsule biz. AZ’s Lynparza in early breast cancer. Trump wants childhood vaccine discussion. See more on our front page

Working here

Quote

anonymous

Guest
obviously there's very little traffic here, but I am curious as to what it's like working here. I've been in pharma for a few years but I also have an animal health background. Can someone tell me what it's like here? Thanks.
 












Been here for 10 years and with the recent purchase of Merial, the culture is at an all time low! Too much Merial influence and BI legacy employees are falling out in mass! Sad but they asked for it!
 






Well, us old folks are retiring ASAP, before the merger costs kills off any more innovation. At least Merial knows how to run a multi product promo. Put a time limit on it, keep everything secret and then announce an extension because ending things mid month is / was stupid. Stupidly successful that is. Although pulling product back from distribution is really stupid if you're not willing to offer the same terms. We're short on billing terms. clinics can get 5 to 6 months terms on Bravecto thru shiny Hank. Give us our money by Christmas. Not to mention the OTC of frontline pissed off a vet or two. Adding a chemical and a new name doesn't quite cut it. Go figure.
 












anonymous said:
obviously there's very little traffic here, but I am curious as to what it's like working here. I've been in pharma for a few years but I also have an animal health background. Can someone tell me what it's like here? Thanks.
Click to expand...

Animal health pharma is more of a direct sale (next day #s)vs rx trends being delayed for 2 months, much better access to decision makers than human pharma.
 






Top Bottom
Back
Quote